{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifx475dh4bhp4xkmvrbrejqdhitjl5pfuhplno4lunnvrx7gtvqry",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mi5jaomxqre2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig5bhmzomqbrru4lh7ghqs4nga6yogvijcqlx4cmh3io56psgngzm"
    },
    "mimeType": "image/jpeg",
    "size": 678722
  },
  "path": "/news/2026-03-ai-chemotherapy-benefit-breast-cancer.html",
  "publishedAt": "2026-03-28T15:00:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short- and long-term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit and which are not.",
  "title": "AI model can predict chemotherapy benefit in breast cancer"
}